2013
DOI: 10.1016/j.neuropharm.2013.04.057
|View full text |Cite
|
Sign up to set email alerts
|

Diphenytoin, riluzole and lidocaine: Three sodium channel blockers, with different mechanisms of action, decrease hippocampal epileptiform activity

Abstract: Epilepsy is a condition affecting 1–2% of the population, characterized by the presence of spontaneous, recurrent seizures. The most common type of acquired epilepsy is temporal lobe epilepsy (TLE). Up to 30% of patients with TLE are refractory to currently available compounds, and there is an urgent need to identify novel targets for therapy. Here, we utilized the in-vitro CA3 burst preparation to examine alterations in network excitability, characterized by changes in interburst interval and bursting thresho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 75 publications
0
11
0
Order By: Relevance
“…It has been reported that riluzole, lidocaine, phenytoin bound to distinct sites of the sodium channels [ 49 , 50 , 51 , 52 ]. For example, riluzole interacts with amino acids residues TYR 1787, LEU 1843 and GLN 1799 located in the transmembrane segment S6 of domain IV of the α-subunit [ 53 ].…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that riluzole, lidocaine, phenytoin bound to distinct sites of the sodium channels [ 49 , 50 , 51 , 52 ]. For example, riluzole interacts with amino acids residues TYR 1787, LEU 1843 and GLN 1799 located in the transmembrane segment S6 of domain IV of the α-subunit [ 53 ].…”
Section: Discussionmentioning
confidence: 99%
“…The stereotypical spontaneous activity patterns in unperturbed networks can be manipulated by changing the balance between inhibition and excitation in the network (Chen and Dzakpasu 2010), applying electrical stimulation (Durand 2009;Wagenaar et al 2005), neuromodulators (Hammond et al 2013;Hasselmo 1995;Whalley et al 2005), pharmacological synaptic blockers (Li et al 2007;Niedringhaus et al 2013;Verstraelen et al 2014), or intrinsic membrane current blockers (Diao et al 2013;van Drongelen et al 2006). Such experimental manipulations provide powerful venues to unravel the diverse mechanisms and critical factors involved in the generation of physiological and pathological network behavior.…”
mentioning
confidence: 99%
“…Here we provided further support for the antiepileptic activity of eugenol by showing that direct application of eugenol (0.5 mM) can prevent or inhibit the PTZ-induced epileptiform activity under in vitro condition. Inhibition of Na + current is an essential mechanism of many antiepileptic drugs (Diao et al, 2013;Ren et al, 2014). Here, the regular action potentials that were recorded after application of eugenol (0.5 mM) on PTZ exposed neurons showed elevated threshold and reduced amplitude and maximum depolarization slope.…”
Section: Discussionmentioning
confidence: 83%
“…Cho et al also reported the inhibitory action of eugenol (0.3 mM) on Na + currents in rat dorsal root ganglion neurons of rat (Cho et al, 2008). The neuroprotective/anticonvulsant agent riluzole employs several mechanisms of actions, but it primarily targets persistent Na + current, which essentially contribute to the neuronal excitability and epileptogenesis (Diao et al, 2013;Ren et al, 2014). Riluzole showed almost comparable effect to that of low concentration eugenol in reducing the frequency, amplitude and slope of rising phase of action potentials and increasing the threshold of action potentials initiation.…”
Section: Discussionmentioning
confidence: 99%